The leading hospital group, Yashoda Hospitals at Somajiguda in Hyderabad, has incorporated one of the most advanced artificial intelligence based integrated PET/CT scanner to detect advanced stage cancers among the patients.
Commemorating the world cancer day, the hospital group installed the state-or-the-art artificial intelligence integrated PET/CT scanner. Dr G Srinivas Rao, director of public health and family welfare, government of Telangana inaugurated the new equipment at the nuclear medicine department and lauded the efforts of the hospital for upgrading with new and highly advanced technological equipments for providing advanced medical diagnosis for the patients in the state.
According to Dr Lingaiah Amidayala, director medical services, Yashoda Hospitals Group, the newly incorporated technology is also known as ‘Time of Flight’. Using the artificial technology, the PET CT scanner will provide best quality images with reduced scanning duration and lesser radiation dose. “Adding state-of-the-art artificial intelligence integrated PET CT scanner, is one more step towards our commitment to early detection of cancer. The new scanner is now two times faster than the old generation scanners primarily due to the advanced technology,” says Dr. Lingaiah.
As already the Yashoda Hospitals at Somajiguda is well equipped with a comprehensive nuclear medicine set up providing services like PET/CT, gamma camera imaging and radionuclide therapy under one roof, now this hospital has become one of leading hospitals in Telangana providing the best healthcare facilities for the cancer patients. Apart from the newly upgraded imaging of FDG PET/CT, the department provides advanced and rare imaging like Ga-68 DOTA, Ga-68 PSMA, 18F DOPA PET/CTs, DAT imaging & WBC scans, a part from routine Gamma imaging like bone scan & renal scintigraphy.
The combined PET/CT Scan merges PET and CT images and provides detailed information about the size, shape and differentiating cancerous lesions from normal structures with accuracy.
Dr. Hrushikesh Aurangabadkar and Dr. A Naveen Kumar Reddy, consultants in nuclear medicine while explaining about the PET/CT and said cancer cells require a great deal of sugar, or glucose, to have enough energy to grow. PET scanning utilizes a radioactive molecule that is similar to glucose, called fluorodeoxyglucose (FDG). FDG accumulates within malignant cells because of their high rate of glucose metabolism. Once injected with this agent, the patient is imaged on the whole body PET scanner to reveal cancer growth, which is usually difficult to characterize by conventional CT, X-ray, or MRI.
|